SP

Sejal Patel

Active Director Director DIN 10802852
DIN 10802852 First appointment Dec 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sejal Patel

Data last updated:

Sejal Patel is a Director at Acrow Pharmachem Private Limited (since 2024). The company operates in Pharma.

DIN 10802852
Primary Designation Director
Industry Pharma
First Appointment 17 Dec 2024
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acrow Pharmachem Private Limited U24233GJ2020PTC115830
Director17 Dec 20242020Active

Directorship timeline

Open interactive timeline →
Acrow Pharmachem Private Limited
Premium access

Shareholding and investment profile for Sejal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sejal Patel

Sejal Patel currently holds 1 directorship: Acrow Pharmachem Private Limited (Director, since 17 Dec 2024).

Sejal Patel was first appointed on 17 Dec 2024 as Director at Acrow Pharmachem Private Limited.

The current boards of Sejal Patel's companies include Dharatiben Jayantibhai Patel (Acrow Pharmachem Private Limited), Dishank Madhavjibhai Patel (Acrow Pharmachem Private Limited), Hasmukhlal Patel (Acrow Pharmachem Private Limited), Hinaben Vipulbhai Patel (Acrow Pharmachem Private Limited), Jay Shaileshbhai Patel (Acrow Pharmachem Private Limited), Jigarkumar Patel (Acrow Pharmachem Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available